<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">Relevium Technologies Inc</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:10000d7e-9554-4f4b-91a9-0759275bc635;id=17558</id> <rights type="text">Copyright 2022, Relevium Technologies Inc</rights> <updated>2022-08-09T18:07:39Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/c7U78lD9ufSeZZH-dm32xw==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/c7U78lD9ufSeZZH-dm32xw==" /> <entry> <id>https://www.globenewswire.com/news-release/2022/08/09/2495214/0/en/Relevium-Announces-Change-in-Auditors.html</id> <title type="text">Relevium Announces Change in Auditors</title> <published>2022-08-09T18:07:39Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2022/08/09/2495214/0/en/Relevium-Announces-Change-in-Auditors.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Aug. 09, 2022 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6iWly44agejQjKAWhikVoGujaa18VGRxfUOOMGaGpsv-O8DdgrAiQvicdtJycnc_Hz9aeE8Awc3zKNi1lx10KbRMij3HqfmnB3T446DuQI4=" rel="nofollow" target="_blank" title="RELEVIUM TECHNOLOGIES INC.">RELEVIUM TECHNOLOGIES INC.</a> (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=uOG-cQZEz-ADlSVtF0yfYq6UnGzjhlh9q3133tbu6rCKXOCcjJ89ab0mw0y8vRS9kH20KDLNHUvPdP0XKQ9HKfrCiLY-eQMIs_JNmCINWHg=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=ZiQ1oMoNXZ7cVq-SF_55fFmRlc6pKBaHZwQOqAX7VxCiuSgQ00WlQFiPM7yQCzTWos3_ibPMG-1xTJ6RAbZIBGT6YZPqEdCpAEK3dFQcEdQ=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=wD_KRJCxhm58EOJDepQtoc6k_jqjvLiUcNGgLBMei_IJZbQhyNUWPxupEp00JpNpD4aUmeNtKPpsGw7z92AVX9TpN_RmJeMbFvNsA8ED0J0OvMlYFkJBG__0mRh2HlNs" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to announce that its board of directors (the “Board”) has approved a change of the Company’s auditor. The Board has appointed Richter LLP (“Richter”) as the new auditor. At the request of Relevium, RSM Canada LLP (“RSM”) has resigned as the Company’s auditor effective as of August 5, 2022, and Richter was appointed as auditor of the Company on the same date.<br></p>]]></content> <dc:identifier>2495214</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Tue, 09 Aug 2022 18:08 GMT</dc:modified> <dc:subject>Directors and Officers</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2022/04/22/2427042/0/en/Relevium-Provides-Operational-and-Continued-Disclosure-Update.html</id> <title type="text">Relevium Provides Operational and Continued Disclosure Update</title> <published>2022-04-22T00:22:22Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2022/04/22/2427042/0/en/Relevium-Provides-Operational-and-Continued-Disclosure-Update.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, April 21, 2022 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=fdsyWUY6J-REXOPlI5de4Uaflzqi1qQZrmyhRzdQ90c4dj2Ji16fkpLIOUtN7m90U2Lu4gAue8zNdHdluKYCjs59js9ZCQOZV_lKvI_7xY4=" rel="nofollow" target="_blank" title="RELEVIUM TECHNOLOGIES INC.">RELEVIUM TECHNOLOGIES INC.</a> (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=yIHJ92jjWStEsXyxLFpzon0Rtg5KA8YwjURwvWhjxxZd5o95Q1KJVAlX1OHr1mgSWoUjc3faypPMgoFTopqDNwOYLbmNLwAt_K0HWT_fKzI=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=018Zexsy0ECXx-kGJz9RxX-HEzPeZhipzcsj20gPj0G_3GKO-f6YSTQnBVTHEdeCOSP2Xbhxej7J9OA1JtahKhHztY5v6bt5OdurNNQbCmw=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=5j_lpFuPVknyBJbHfsK73lf9wkClA2pixj9fPHdy10uYf9vqvt_lulykPkfB_yYqL0ZntcGYNI0uo_BSAxdcA4hiWTK0ksLGluzEdC5IfqYPPhH-cz8MYghwqKIox1az" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to provide an update on operations and continuous disclosure matters.<br></p>]]></content> <dc:identifier>2427042</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Fri, 22 Apr 2022 00:22 GMT</dc:modified> <dc:subject>Management statements</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2022/02/11/2383931/0/en/Relevium-Provides-Operational-and-Continued-Disclosure-Update.html</id> <title type="text">Relevium Provides Operational and Continued Disclosure Update</title> <published>2022-02-11T21:56:01Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2022/02/11/2383931/0/en/Relevium-Provides-Operational-and-Continued-Disclosure-Update.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="left">MONTREAL, Feb. 11, 2022 (GLOBE NEWSWIRE) -- <strong> </strong><a href="https://www.globenewswire.com/Tracker?data=5W1x7oTKxB1O4GyyUFh2SexkiSOSScabXWszIp9pHMHWn31USwZBlhY63MBWnYASBjM3gdqg3E-dTE9u5uXR8xhz4EcPEE55nvPwi5NP840=" rel="nofollow" target="_blank" title="RELEVIUM TECHNOLOGIES INC.">RELEVIUM TECHNOLOGIES INC.</a> (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=txEzAVLGm68bwdv0hkikNWxMLmCOvRvtwmXoK4Apx0s2Tlhql4My4ezyNARPK4SVTkzUhf3sEFfRU1Q1EZIqyp_ed9e5gk_P7dVhG3LTtcg=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=GuvPl5ayLsVrOw53rzFLhC-i7bEHb1AzJdukEDAalRmbBOgewWEoprBlloxQojh8EDu1mx9BpI7dbaysfTSXLHOuzDBrR7AvNFFzXfp-gnI=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=NULcLBKyPtrljCtt15yqreOAe0VXkhsHCRtfGIMIi6rNEMHs-Op9kYWCIhZG9_gzyTe6PwdiQL6KuadunSlTC5avID0K9QcCs_K0hxQzayYnGdKPtarjhnmMBtY5UjBZ" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to provide an update on operations and continuous disclosure matters.<br></p>]]></content> <dc:identifier>2383931</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Fri, 11 Feb 2022 21:56 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2022/01/05/2361944/0/en/Relevium-Provides-Bi-Weekly-Update-to-Management-Cease-Trade-Order.html</id> <title type="text">Relevium Provides Bi-Weekly Update to Management Cease Trade Order</title> <published>2022-01-05T18:13:05Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2022/01/05/2361944/0/en/Relevium-Provides-Bi-Weekly-Update-to-Management-Cease-Trade-Order.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTRÉAL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required filing deadline of October 28, 2021 (the “Filing Deadline”).</p>]]></content> <dc:identifier>2361944</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Wed, 05 Jan 2022 18:13 GMT</dc:modified> <dc:subject>Company Regulatory Filings</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/12/18/2354815/0/en/Relevium-Provides-Bi-Weekly-Update-to-Management-Cease-Trade-Order-and-Shares-for-Debt-Settlement.html</id> <title type="text">Relevium Provides Bi-Weekly Update to Management Cease Trade Order and Shares for Debt Settlement</title> <published>2021-12-18T19:13:37Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/12/18/2354815/0/en/Relevium-Provides-Bi-Weekly-Update-to-Management-Cease-Trade-Order-and-Shares-for-Debt-Settlement.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="left">MONTRÉAL, Dec. 18, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required filing deadline of October 28, 2021 (the “Filing Deadline”).<br></p>]]></content> <dc:identifier>2354815</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Sat, 18 Dec 2021 19:14 GMT</dc:modified> <dc:subject>Stock Market News</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/12/16/2353874/0/en/Relevium-Secures-Two-PPE-Contracts-Totaling-16-Million-Contracts-Result-in-Record-Revenues-and-Earnings-for-Q2-and-for-FYE-June-30-2022.html</id> <title type="text">Relevium Secures Two PPE Contracts Totaling $16 Million; Contracts Result in Record Revenues and Earnings for Q2 and for FYE June 30, 2022</title> <published>2021-12-16T15:25:47Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/12/16/2353874/0/en/Relevium-Secures-Two-PPE-Contracts-Totaling-16-Million-Contracts-Result-in-Record-Revenues-and-Earnings-for-Q2-and-for-FYE-June-30-2022.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Dec. 16, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4igLKCY5LjNlUKydVWCs0H0zvM7HwuU5TqcqDTz6p0Nr9HXPZQjzN2iIPfY8ooLoOcO9yAq-7oytfoDLWg1E_zjitSeGG2g10MZ8p-mRwww=" rel="nofollow" target="_blank" title="RELEVIUM TECHNOLOGIES INC.">RELEVIUM TECHNOLOGIES INC.</a> (TSX.V: “<a href="https://www.globenewswire.com/Tracker?data=7BLJA_RTYrLEecjnPzG58s_kLpyKWnutmA0hrnPMnxeJHj5G1o_4q7Pu8H3KqiVNqqol7zoh_WuP8ZU9Z4rxpxTlPrjLGsgz_XbzOWWmXNo=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB: “<a href="https://www.globenewswire.com/Tracker?data=8B3_Zy7B8pv0oq4a1dP0TsyBEkhPglFv1RIKLvOxiyUFwwT_ysFAyD8UkJHj94_1CaKDsEDMRCDu46EI1bNFwtiS7LQbeniLND5Fh4-OX5Y=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=JZViXtlcFqRBdZ2DGq_aHmVgkfVozKgnuVIGDeR1ztUMdGR3EOjs83dkabkZU8d163nlfYQFjk-9vGswm4llzvQqI37jeDJSv3TjEXcdV7352zW82U3tjECU3WzK4J2w" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to announce today that in the month of December it secured two PPE contracts valued at CAD$11million and CAD$5 million respectively to supply a total a total of 180 million medical grade nitrile gloves.<br></p>]]></content> <dc:identifier>2353874</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 16 Dec 2021 15:26 GMT</dc:modified> <dc:subject>Business Contracts</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/11/30/2343399/0/en/Relevium-Provides-Update-to-Management-Cease-Trade-Order-and-Other-Matters.html</id> <title type="text">Relevium Provides Update to Management Cease Trade Order and Other Matters</title> <published>2021-11-30T16:35:20Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/11/30/2343399/0/en/Relevium-Provides-Update-to-Management-Cease-Trade-Order-and-Other-Matters.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTRÉAL, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required filing deadline of October 28, 2021 (the “Filing Deadline”).<br></p>]]></content> <dc:identifier>2343399</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Tue, 30 Nov 2021 16:35 GMT</dc:modified> <dc:subject>Stock Market News</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/11/23/2339856/0/en/Relevium-Significantly-Strengthens-its-JV-Operations-by-Entering-Into-an-Agreement-to-Acquire-100-of-Terry-Booth-s-MED-PPE-CANADA.html</id> <title type="text">Relevium Significantly Strengthens its JV Operations by Entering Into an Agreement to Acquire 100% of Terry Booth’s MED PPE CANADA</title> <published>2021-11-23T13:54:37Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/11/23/2339856/0/en/Relevium-Significantly-Strengthens-its-JV-Operations-by-Entering-Into-an-Agreement-to-Acquire-100-of-Terry-Booth-s-MED-PPE-CANADA.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Nov. 23, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Sa4V23ChTnn34TufJzLedHa39H86KRbcAqNdN25SHAK6gZTLrGtkBKEELMQg1j-vCJ2iFx4I8OwgvmQ0OwP37XStT7XR1WkMIVd6cwedqgw=" rel="nofollow" target="_blank" title="RELEVIUM TECHNOLOGIES INC.">RELEVIUM TECHNOLOGIES INC.</a> (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=bvHvdnrcr5WhwAOKfiYPClDVonJfOr4HCmf8WYFe7bGqBQX23pnK4MUf-Gp8VlXt_VwMLjxOBC_CUgjS07yZjWzh3eAvTDFaCQjuGr_ZowQ=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=ZoJJZfiH8XysD315XVXsRjp0kn04ehq_pDw_Z3ISMk-RIgFBc0TKToDYPGlc0xv3ggsfXxMHIEPYbIJnT481XIanaf4xgkC6N45nErNhgPc=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=8WF5_kfl3PIysf8-ZcY2FYyomP1hc74kMs__HWTqJOHTTFZOZK8969KLNfoZvvdkbWmkCi1geiRUYZssiAX8pnDtVoq20Y3_VsiJV3nZmUB7WvV8CWhO1AKyB702S5hU" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), a company operating in the Personal Protective Equipment (“<strong>PPE</strong>) sector, is pleased to announce today it has entered into a non-binding term sheet (“<strong>Term Sheet</strong>”) in respect of a proposed acquisition of all the issued and outstanding shares of <strong>MED PPE CANADA INC</strong>. (“<strong>Med PPE</strong>”), a distributor of medical equipment, purification systems, and PPE and supplies to the Canadian market.</p>]]></content> <dc:identifier>2339856</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Tue, 23 Nov 2021 13:55 GMT</dc:modified> <dc:subject>Joint Venture</dc:subject> <dc:subject>Mergers and Acquisitions</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/11/19/2338312/0/en/Relevium-Provides-Update-to-Management-Cease-Trade-Order-and-Other-Matters.html</id> <title type="text">Relevium Provides Update to Management Cease Trade Order and Other Matters</title> <published>2021-11-19T14:11:44Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/11/19/2338312/0/en/Relevium-Provides-Update-to-Management-Cease-Trade-Order-and-Other-Matters.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended June 30, 2021, including the CEO and CFO certifications (collectively, the “Annual Financial Filings”) that were not filed by the required filing deadline of October 28, 2021 (the “Filing Deadline”).<br></p>]]></content> <dc:identifier>2338312</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Fri, 19 Nov 2021 14:12 GMT</dc:modified> <dc:subject>Company Regulatory Filings</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/11/01/2324922/0/en/Relevium-Announces-Delay-in-Filing-Annual-Financial-Statements.html</id> <title type="text">Relevium Announces Delay in Filing Annual Financial Statements</title> <published>2021-11-01T22:14:47Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/11/01/2324922/0/en/Relevium-Announces-Delay-in-Filing-Annual-Financial-Statements.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTRÉAL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX-V : RLV, OTC : RLLVF, and Frankfurt : 6BX) (the “<strong>Company</strong>” or “<strong>Relevium</strong>”) announces that its annual financial statements for the year ended June 30, 2021, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the “<strong>Annual Financial Filings</strong>”) have not been filed by the required filing deadline of October 28, 2021 (the “<strong>Filing Deadline</strong>”).<br></p>]]></content> <dc:identifier>2324922</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Mon, 01 Nov 2021 22:15 GMT</dc:modified> <dc:subject>Company Regulatory Filings</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/10/01/2307311/0/en/Relevium-Technologies-Completes-Shares-For-Debt-Transactions.html</id> <title type="text">Relevium Technologies Completes Shares-For-Debt Transactions</title> <published>2021-10-01T18:47:19Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/10/01/2307311/0/en/Relevium-Technologies-Completes-Shares-For-Debt-Transactions.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“<strong>RLV</strong>”, OTCQB:“<strong>RLLVF</strong>” and Frankfurt: “<strong>6BX</strong>”) (the “<strong>Company</strong>” or “<strong>Relevium</strong>”) is pleased to announce that it has completed its previously announced shares-for-debt settlements pursuant to which the Company has settled an aggregate of $2,434,439.16 of debt with certain holders of outstanding notes through the issuance of a total of 121,721,958 common shares in the capital stock of the Company at a deemed price of $0.02 per share (the “<strong>Shares-for-Debt Settlements</strong>”).<br></p>]]></content> <dc:identifier>2307311</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Fri, 01 Oct 2021 18:48 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/08/10/2278101/0/en/Relevium-Obtains-Conditional-TSXV-Approval-for-the-Settlement-of-the-Outstanding-Notes-in-Shares.html</id> <title type="text">Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares</title> <published>2021-08-10T13:48:43Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/08/10/2278101/0/en/Relevium-Obtains-Conditional-TSXV-Approval-for-the-Settlement-of-the-Outstanding-Notes-in-Shares.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Aug. 10, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ALQS7yqua_qnnioGA4IGRGjk8imPbKpVFktCcKicpsStaLVPgXCbz8L6Zk7Lg9e5bs2PTY87X_QyohP6YCzzvFJR0hfjsAlbHCIRs7rKp4c=" rel="nofollow" target="_blank" title="Relevium Technologies">Relevium Technologies</a> Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=ABrwJnYhU99NDtU8nsN7vNHpsy7fZEQ52KrEA2TcgHIJrFcJV0b2BTlQDnOyqPZOjLfUabKmg1hk5SG3ebHGVUenboHlS5QjMqL6c3X_rnI=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=lik21xn4QslL--Wl6mzh_J7Zteml6XFgObHKbpTl0du8TmQz2C2uxsvZ6ruzvgxAbMC9tibu_lp_FH5bzERp60kCnXtwoIUQ2IK8KsQsdX0=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=SugEirPc-zXIK89rIzt4zJ5NP7SQuL0a9lsd7A1zDAGXVxpS7ePAifHNR9LjbrpiSUu1lMJZNkjZ86Cjh1gNL4D9qXMAsxNqaP5w9dHWawkiRWZ62eAoag0m5jeSvADg" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), announced today it has received conditional approval from the TSX Venture Exchange for the settlement in shares of the outstanding notes totalling $2,434,439.<br></p>]]></content> <dc:identifier>2278101</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Tue, 10 Aug 2021 13:49 GMT</dc:modified> <dc:subject>Stock Market News</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/06/30/2255902/0/en/Relevium-Announces-Settlement-of-the-Outstanding-Notes.html</id> <title type="text">Relevium Announces Settlement of the Outstanding Notes</title> <published>2021-06-30T15:19:05Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/06/30/2255902/0/en/Relevium-Announces-Settlement-of-the-Outstanding-Notes.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, June 30, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=w7MqWO7w274C1misH4T0kHsVYXdr92xQ668gjbfjKegp-BvSWD5yW9lReu2OIxIyvjZwhbxhjIENZkmPVL5DToI-a4vI0fgENfmPLe9p-58=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u> </a>Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=91iHtmiCIX7f08ksQV8HPNCHP8H7S_1h9LCq3zYEB-LpOjLVjUsghHQtIWaZM6zgLrukeKgJw7jDqyMT12VRahEH5Kb9xbxcbfCPC7Qw_a8=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=l66TFYmB-2RUE53XpNrQ2n9DZX0x_S2C3ZWFSWYj-PQBkoQU4mK6MY2X4TBemJ0pQU4eB_ocqVuzdhao5Z34hLbGvUj4fEFHocktXAIlyQo=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=xVnvlcVFr2rZuOkJAw5uvNry4oxC8Q2WYBdIuyRKdH6yoL2EDwYWGrRi7Vqab1MBjQIZ4hB0DKar115VC55qsfWL0kBSoKRyQgJRR3qL5IILG6tFm1TWFetzX5LBQ5nJ" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), announces today it has reached an agreement to settle the outstanding notes totalling $2,798,550.<br></p>]]></content> <dc:identifier>2255902</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Wed, 30 Jun 2021 15:19 GMT</dc:modified> <dc:subject>Stock Market News</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/06/15/2247507/0/en/Relevium-Announces-Shareholder-Townhall-and-Conference-Call.html</id> <title type="text">Relevium Announces Shareholder Townhall and Conference Call</title> <published>2021-06-15T14:11:57Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/06/15/2247507/0/en/Relevium-Announces-Shareholder-Townhall-and-Conference-Call.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=msbcSNkalrSBsLW06RqB35w7fWPnGeag1cfCFev9K7pLrFly1NzfLyD2JeXMmAoEood2Udd6jSpdlatxrp_nTviUtgGSGYralaPByJCX71k=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u> </a>Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=xP46vkko6ArKcM2xb5w9Jkc43cEuMEY5A7rQasBn8ZGMQk1iNviWaK0ys5NSO9k8VZRwWQbFJ05YyID-FNRjtmmo3YDwvhmcSJ4695BY-tY=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=IxURuxU8efuRSxlEpc6AAA_buiADjUvCo6CwdbeBHMNgXCiw5swN3ZoWvJqsw-wHQ643D2KLmULhWh6MhiJJrL_Danu_qA9civBuIaZGVnk=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=kfukavHubPOrbUgcSb7pWOL1aHMswkLnMUFz4ayIariGeftTrweEFEQhT2Zd6P45DH59VSZp6RmOJjM4b8pE_g20wYXWL4IgyXQl5BBzIm7rMkpMvsgQfQGyx_RffzB1" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to invite all shareholders, partners, affiliates and interested parties to attend a “<strong>TOWN HALL</strong>” Investor Relations conference call to be hosted by Aurelio Useche, CEO on <a href="https://www.globenewswire.com/Tracker?data=wT_RsMz8Ym7ZyR3HUJq_ehVObvQa0SV3PRlJ55zg3hFpqH_0OVQ-UNUU4IpDv1p6xu4VCARO8rU0sV_uvVJytYGjvPJRqtLchqRHDwmWCUBRfTerD98wHwy8SXjmRi__uC_5ttPHwDVPY7g8qPoOW1UtwRHaoz17mwxg8FNKkjtoivYa0qPTCfcy0ja5_4wN_ZDQdX1XL-fzwNUOxkBvZQ==" rel="nofollow" target="_blank" title="Wednesday, June 30, 2021 at 4:15 PM Eastern Standard Time.">Wednesday, June 30, 2021 at 4:15 PM Eastern Standard Time.</a><br></p>]]></content> <dc:identifier>2247507</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Tue, 15 Jun 2021 14:12 GMT</dc:modified> <dc:subject>Annual Meetings & Shareholder Rights</dc:subject> <dc:subject>Calendar of Events</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/06/10/2245204/0/en/Relevium-Announces-Maturity-of-the-Outstanding-Convertible-Debenture-Notes-and-Begins-Negotiations-With-Debenture-Holders.html</id> <title type="text">Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders</title> <published>2021-06-10T12:11:39Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/06/10/2245204/0/en/Relevium-Announces-Maturity-of-the-Outstanding-Convertible-Debenture-Notes-and-Begins-Negotiations-With-Debenture-Holders.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=xIcdQn0vKDlL_uyn6-Wteql4rF52rmhySdoUjiBiGG5vzImK3S-P-FgaxWjbFbEcrVQ_693W5mRgVJ9Hv76-sQeAsLmt17zkUm0E3msActM=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u></a> Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=peaHXB3p5Ajy7WQIdeJ7H8A7IUCX2qjx_Ns-hTBgxONWxrfWoe_Rwr5JtO2dq9bsIdYVssd-oBcdsKp6nJjKrkfPeHCGd7OTGbVMjAmSWCw=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=Aq5AlACllusD9qj9DdvQdKCUNgdNhLmifRWJslhD7b43rT-RwRXNknkJjxiWq0QY8FRbSfrVTtt871g8GFEf_DEwLWmK5aSRlCWkI-Q2udk=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=uMrHj1JYwNRbPwQEMyf2aIRqP2JerZup5p3bvW1hhiADo2eSv8p7kZ9sjeYz3PR6N0g-QuMukUTM65LxeZ2bypnXUnDdpav76jGqJIvFNysur93bEI8t4b-9uqC7zMYW" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), announces today the maturity of its outstanding convertible debenture notes and that it has begun the process of negotiating their settlement with the debenture note holders.<br></p>]]></content> <dc:identifier>2245204</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 10 Jun 2021 12:11 GMT</dc:modified> <dc:subject>Stock Market News</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/05/20/2233006/0/en/Relevium-Announces-the-Appointment-of-Dr-Wolfgang-Renz-as-Chief-Scientific-Officer-for-Biocannabix-Health-Corporation.html</id> <title type="text">Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation </title> <published>2021-05-20T06:00:00Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/05/20/2233006/0/en/Relevium-Announces-the-Appointment-of-Dr-Wolfgang-Renz-as-Chief-Scientific-Officer-for-Biocannabix-Health-Corporation.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=fCUy89voSiNCwqYLSjLSUl58lx5KO0l_s9nPHAIrTV3kmnwYY2iNaCC69YI5ekbZslCBcohrqhcS5f_a4f03tadHtYvX4pHVRnUeHql-cS0=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u> </a>Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=skoA9xigmrq6tU487cPuwVN3_hu20CguiTbTAHLbx3GPlnSUcrVkHUZJ-lUs7q-i0ObN_wg241RnIAqgcSEzhakTpgRZzywPSAo7qE9-wkA=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=B4mGf6AWjd7Cd3V0Q34dX72Xmjw06zupXrHnClp_8GjAqIe0AEq9KguoLr2dFElehjzyxuzW2E-mX8Cp2Y9gzTAdSzCYbgh7gZsxgj5n0jc=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=bcEB5eKbbCGwrhhYJ6N6k00B7JepCZOyE0PDsTykvJ8CbGbiVILrtRz41dpHRnp78z1pMYe8lxB6pfudNS0J8NSz4AMVNo8OXlGq5c6ugKOTKjOvDzOOg-HX7GCLK2Su" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), and its’ wholly-owned subsidiary, <strong>Biocannabix Health Corporation (</strong>the “<strong>BCX”)</strong>, a company focused on international research and development for cannabinoids, nutraceuticals and medical food formulations, is pleased to announce the appointment of Dr. Wolfgang Renz as Chief Scientific Officer and Advisor.<br></p>]]></content> <dc:identifier>2233006</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 20 May 2021 06:00 GMT</dc:modified> <dc:subject>Directors and Officers</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/05/05/2223588/0/en/Relevium-Provides-Update-on-the-Exclusive-Supply-of-Medical-Examination-Gloves.html</id> <title type="text">Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves</title> <published>2021-05-05T13:47:29Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/05/05/2223588/0/en/Relevium-Provides-Update-on-the-Exclusive-Supply-of-Medical-Examination-Gloves.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=jPa2b9fq53GgEXltjuj-2x11anx14NMCJanqgYTVak4HBFWRod3uel8PtsR3WcXfpWF3e0OxPs0pSLZOPIkSe5_xilgXYorhx8216Dd4F08=" rel="nofollow" target="_blank" title="Relevium Technologies Inc.">Relevium Technologies Inc.</a> (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=v1qjApo3DnJ4iGxt62uSyStNpsOs0x-ddoJ1lVxyPrKLsJmkpnNl6zBOuQOxMRs3r7zPTyfV1JP49A46Vc0dn_rKaoudwkzL9S_nEbMkX1c=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=uJMqt95JeSMIyx_UPjYkcWmq-WCXfTXDr9T_frzbI3NL8ftOWfN3c-_oCBmdrpo0E4ofHgTev0Hf8rl63bZVBei4ql_RQ-AJkNV5ECeeXh0=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=haH0iCwtutYcFtVPrkL2JPDz-QfK080ULwfpIw1dLnrk6JEmx_rBRVp3chQDFIZdQt-zBp8M7y7ZlRcf9KSXxSrqp7T3-MNvkpJrArTyrDDY_Hk0HrE_qc9h5XDDMb79" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), whose primary mandate is to focus on international procurement, logistics, and delivery of Personal Protective Equipment (“<strong>PPE</strong>) and wellness products, is pleased to provide an update on the performance of the exclusivity contract to supply medical examination gloves for North America.<br></p>]]></content> <dc:identifier>2223588</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Wed, 05 May 2021 13:47 GMT</dc:modified> <dc:subject>Business Contracts</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/04/29/2219871/0/en/Biocannabix-Enters-Into-LOI-With-IAM-Health-GmbH.html</id> <title type="text">Biocannabix Enters Into LOI With IAM Health GmbH</title> <published>2021-04-29T13:12:13Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/04/29/2219871/0/en/Biocannabix-Enters-Into-LOI-With-IAM-Health-GmbH.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=BYf2Fi30KkNtt-r2e2PfS_THMlqh_9ivezkSv5ji2JqS61wYDKpEY0mNCH-lMzSZZPGWQXLgOwxsSr0x92sL9Dbq6OIxmIIkkadraDwAx8E=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u></a> Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=MrV5t_GEPw6Qvhsf_HSPsHm3X2REgoGpF-PS8JguhrwX-tt4XpLiSoyblTGXd155lK_qe7fdnceIwpx2Z9K9ZKDLDkNsneL2FxwLJX6p0yU=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=A7ctZFb337n8toKT06uK5wyjfYhRXcPX23ZqPkmefY6E1vMZl47WRqrpPcbgIiFjvJ_KgJHbGQQfBwbVqYjLpyLmrZBM0AqjtuJr-sORsdg=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=ONWgthduepZhMvZdQ3VHP96v7YM3dDf4QKfhmfgJQSKRp4rjzxt9dXjLGZrZSwaTN-I8v4RJ-1YfP0OA-Mdai1w0eJW7QasmX1XMoMaxjNQBKQEVRCPReai48K-gFefL" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), and its’ wholly-owned subsidiary, <strong>Biocannabix Health Corporation (</strong>the “<strong>BCX”)</strong>, a company focused on Paediatric and Geriatric applications of Cannabinoid nutraceutical and medical food formulations, is delighted to announce that it has entered in a Letter of Intent (the “<strong>LOI</strong>”) with <strong>IAM Health GmbH (</strong>the “<strong>IAM”)</strong>, a German based Research & Development company, to pursue a number of pre-defined research opportunities.</p>]]></content> <dc:identifier>2219871</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 29 Apr 2021 13:12 GMT</dc:modified> <dc:subject>Mergers and Acquisitions</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/03/11/2191660/0/en/Relevium-Secures-North-American-Exclusivity-for-Medical-Examination-Gloves-with-First-Shipment-to-Arrive-in-Los-Angeles-by-Mid-April.html</id> <title type="text">Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April</title> <published>2021-03-11T18:59:33Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/03/11/2191660/0/en/Relevium-Secures-North-American-Exclusivity-for-Medical-Examination-Gloves-with-First-Shipment-to-Arrive-in-Los-Angeles-by-Mid-April.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=nW9nOfZ7hRvpjeG8YxE40nQ-YkDeF4bqYZA7b9611xguGs-kxWYKB6Tt4G7E53fzOoaWIkkIaSp746GIJgQFExZ0-BC0bTCmmvoGvzrUaqc=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u> </a>Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=5WiUY469Id17WsAPMeGMKK63l-awLCkQQBqjcJaHVPe5aCmUbGlLG3n6WtHqOkChNJEXGsFQnuLTQuz77q8GePKBbeYfcpqRFfNgToKBBpI=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=p8MZdPCboFeMFI7ZcOYxhmxWLs3ZulBtaxSDDBeNjJ7vktzZLORJxVBBPzYU24_sCHGlaepv0pc4-1zoxl1z-Yozwr7YBWnFqxpnba0rvmw=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=D4JAQTzOdiMqmxmbq-8TrBgaFnMMwIqdoFFI2IDL9SDWaBY2STm_tAfRAmQACMsjPA2SSQhwOpp-FTRdY6Try9ofXXl2Mj9ZrcsJXsMUSXq77T5tt7T5-Kqy70rSMxC1" rel="nofollow" target="_blank" title="">“<u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to announce the company has secured delivery of the delivery of first production batch Personal Protective Equipment (“PPE”) from the a supply agreement entered into the last quarter of 2020 with 24 Clean Energy (the “<strong>Supplier</strong>”), a manufacturer and distributor of high-end medical grade nitrile gloves. Relevium has also obtained the exclusive North American rights to market the “<strong>DI-Line”</strong> brand of medical grade gloves, a much needed and sought-after PPE product.<br></p>]]></content> <dc:identifier>2191660</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 11 Mar 2021 19:01 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </entry> <entry> <id>https://www.globenewswire.com/news-release/2021/02/04/2170365/0/en/Relevium-Announces-Investor-Relations-Conference-Call.html</id> <title type="text">Relevium Announces Investor Relations Conference Call</title> <published>2021-02-04T21:48:03Z</published> <updated>2024-12-03T00:57:35Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2021/02/04/2170365/0/en/Relevium-Announces-Investor-Relations-Conference-Call.html" /> <category term="TSX-V:RLV" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Other OTC:RLLVF" scheme="https://www.globenewswire.com/rss/stock" /> <category term="Frankfurt:6BX" scheme="https://www.globenewswire.com/rss/stock" /> <category term="CA75942W1023" scheme="https://www.globenewswire.com/rss/ISIN" /> <content type="html"><![CDATA[<p align="justify">MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=VC3Pm1wDG2W7wR1S8LHWT_JPB5VXN1IkKd0si5H_cTqqaTY4jICdzAakEGvbnn3n9Wib3fRAkXyTVfFSsV1Sdc5Rl0T70GmAk1jmdQgaBxM=" rel="nofollow" target="_blank" title=""><u>Relevium Technologies</u> </a>Inc. (TSX.V:“<a href="https://www.globenewswire.com/Tracker?data=O6Ojztxtkvn-CHv93YTmEFJvkKl5FYCgWBAh_sA5tD5PpdWVTdmGQ7g8nfOHEKqehijNMr3qdDkmNDxnCG-ltTc2sLC0wy0ciHJUhyLwtk0=" rel="nofollow" target="_blank" title=""><u>RLV</u></a>”, OTCQB:“<a href="https://www.globenewswire.com/Tracker?data=16Sz2OXuZ6nkgM58hH9zXV6tSJY3J9eBHhILC7Q5_9MYgadAH7OIvW-CA22WzHb1KLs7oMzEtgMwScFKi7jlb5tRtHjQdSWiYnD9n3uMDto=" rel="nofollow" target="_blank" title=""><u>RLLVF</u></a>” and Frankfurt: <a href="https://www.globenewswire.com/Tracker?data=b7IktE3KWxUdbqJlYEuRDEUivRWwSG48ixNpDqCAAzeTZkhhwAQYWo87oZWvSixbCVNi4Pks2SHamZ_PnSE78nDA1qBMljsQBWSIwTF_vdZ55iZWMmfG8aK84YYhFzXY" rel="nofollow" target="_blank" title="“">“</a><a href="https://www.globenewswire.com/Tracker?data=KINnPGab__NqbxemfpSRu4ZL6tTSMDRL_MdryxqTuIwluu_phmHN02cByGCUGTV9RlRsDfWQapBK66MbaamFErvSz4KRRGoM7s_WuRsAVA1-x_uzSuh84tCoF36H6vMI" rel="nofollow" target="_blank" title=""><u>6BX</u></a>”) (the “<strong>Company</strong>” <strong>or </strong>“<strong>Relevium</strong>”), is pleased to invite all shareholders, partners, affiliates and interested parties to attend a “town hall” Investor Relations conference call to be hosted by Aurelio Useche, CEO.<br></p>]]></content> <dc:identifier>2170365</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Relevium Technologies Inc</dc:contributor> <dc:modified>Thu, 04 Feb 2021 21:48 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </entry> </feed>